Atlas Trials

AFPᶜ³³²T in Advanced HCC

Clinical trial NCT03132792 · COMPLETED

Trial details

NCT number
NCT03132792
Sponsor
Adaptimmune
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular CancerAFP Expressing Tumors
Start date
2017-05-08
Primary completion
2021-07-07
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.